Pharmaceuticals

United States Insulin Detemir Market Report 2016

  • QYR681992
  • 116 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Insulin Detemir

Revenue, means the sales value of Insulin Detemir

This report studies sales (consumption) of Insulin Detemir in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Novo Nordisk

MNKD

Bristol-Myers Squibb Company

Emisphere

Biocon

...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Insulin Detemir in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Insulin Detemir Market Report 2016

1 Insulin Detemir Overview

1.1 Product Overview and Scope of Insulin Detemir

1.2 Classification of Insulin Detemir

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Insulin Detemir

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Insulin Detemir (2011-2021)

1.4.1 United States Insulin Detemir Sales and Growth Rate (2011-2021)

1.4.2 United States Insulin Detemir Revenue and Growth Rate (2011-2021)

2 United States Insulin Detemir Competition by Manufacturers

2.1 United States Insulin Detemir Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Insulin Detemir Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Insulin Detemir Average Price by Manufactures (2015 and 2016)

2.4 Insulin Detemir Market Competitive Situation and Trends

2.4.1 Insulin Detemir Market Concentration Rate

2.4.2 Insulin Detemir Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Insulin Detemir Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Insulin Detemir Sales and Market Share by Type (2011-2016)

3.2 United States Insulin Detemir Revenue and Market Share by Type (2011-2016)

3.3 United States Insulin Detemir Price by Type (2011-2016)

3.4 United States Insulin Detemir Sales Growth Rate by Type (2011-2016)

4 United States Insulin Detemir Sales (Volume) by Application (2011-2016)

4.1 United States Insulin Detemir Sales and Market Share by Application (2011-2016)

4.2 United States Insulin Detemir Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Insulin Detemir Manufacturers Profiles/Analysis

5.1 Novo Nordisk

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Insulin Detemir Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Novo Nordisk Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 MNKD

5.2.2 Insulin Detemir Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 MNKD Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bristol-Myers Squibb Company

5.3.2 Insulin Detemir Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bristol-Myers Squibb Company Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Emisphere

5.4.2 Insulin Detemir Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Emisphere Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Biocon

5.5.2 Insulin Detemir Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Biocon Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

...

6 Insulin Detemir Manufacturing Cost Analysis

6.1 Insulin Detemir Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Insulin Detemir

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Insulin Detemir Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Insulin Detemir Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Insulin Detemir Market Forecast (2016-2021)

10.1 United States Insulin Detemir Sales, Revenue Forecast (2016-2021)

10.2 United States Insulin Detemir Sales Forecast by Type (2016-2021)

10.3 United States Insulin Detemir Sales Forecast by Application (2016-2021)

10.4 Insulin Detemir Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Insulin Detemir

Table Classification of Insulin Detemir

Figure United States Sales Market Share of Insulin Detemir by Type in 2015

Table Application of Insulin Detemir

Figure United States Sales Market Share of Insulin Detemir by Application in 2015

Figure United States Insulin Detemir Sales and Growth Rate (2011-2021)

Figure United States Insulin Detemir Revenue and Growth Rate (2011-2021)

Table United States Insulin Detemir Sales of Key Manufacturers (2015 and 2016)

Table United States Insulin Detemir Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Insulin Detemir Sales Share by Manufacturers

Figure 2016 Insulin Detemir Sales Share by Manufacturers

Table United States Insulin Detemir Revenue by Manufacturers (2015 and 2016)

Table United States Insulin Detemir Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Insulin Detemir Revenue Share by Manufacturers

Table 2016 United States Insulin Detemir Revenue Share by Manufacturers

Table United States Market Insulin Detemir Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Insulin Detemir Average Price of Key Manufacturers in 2015

Figure Insulin Detemir Market Share of Top 3 Manufacturers

Figure Insulin Detemir Market Share of Top 5 Manufacturers

Table United States Insulin Detemir Sales by Type (2011-2016)

Table United States Insulin Detemir Sales Share by Type (2011-2016)

Figure United States Insulin Detemir Sales Market Share by Type in 2015

Table United States Insulin Detemir Revenue and Market Share by Type (2011-2016)

Table United States Insulin Detemir Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Insulin Detemir by Type (2011-2016)

Table United States Insulin Detemir Price by Type (2011-2016)

Figure United States Insulin Detemir Sales Growth Rate by Type (2011-2016)

Table United States Insulin Detemir Sales by Application (2011-2016)

Table United States Insulin Detemir Sales Market Share by Application (2011-2016)

Figure United States Insulin Detemir Sales Market Share by Application in 2015

Table United States Insulin Detemir Sales Growth Rate by Application (2011-2016)

Figure United States Insulin Detemir Sales Growth Rate by Application (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novo Nordisk Insulin Detemir Sales Market Share (2011-2016)

Table MNKD Basic Information List

Table MNKD Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

Table MNKD Insulin Detemir Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Company Basic Information List

Table Bristol-Myers Squibb Company Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Company Insulin Detemir Sales Market Share (2011-2016)

Table Emisphere Basic Information List

Table Emisphere Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

Table Emisphere Insulin Detemir Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Insulin Detemir Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Insulin Detemir Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Insulin Detemir

Figure Manufacturing Process Analysis of Insulin Detemir

Figure Insulin Detemir Industrial Chain Analysis

Table Raw Materials Sources of Insulin Detemir Major Manufacturers in 2015

Table Major Buyers of Insulin Detemir

Table Distributors/Traders List

Figure United States Insulin Detemir Production and Growth Rate Forecast (2016-2021)

Figure United States Insulin Detemir Revenue and Growth Rate Forecast (2016-2021)

Table United States Insulin Detemir Production Forecast by Type (2016-2021)

Table United States Insulin Detemir Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370